Results 81 to 90 of about 305 (130)

ANALYSIS OF QUALITY INDICATORS AND PARAMETRS OF SYRUP AMBROXOL PRODUCTION USING STATISTICAL METHODS

open access: yesРазработка и регистрация лекарственных средств, 2019
The quality review procedure, which is an essential improvement of the quality system by manufacturers, was used for monitoring the stability of the production process and quality of Ambroxol syrup.
S. N. Egorova   +3 more
doaj  

Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation

open access: yesPharmaceutics
Background: This study explores the development and characterization of spray-dried composite microparticles consisting of levofloxacin (LVX, a broad-spectrum antibiotic), and ambroxol (AMB, a mucolytic agent that has antibacterial and antibiofilm ...
Ruwani K. Suraweera   +5 more
doaj   +1 more source

Ambroxol, the cough expectorant with neuroprotective effects

open access: yesNeural Regeneration Research
Kristin Patzwaldt   +1 more
openaire   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Antioxidant properties of ambroxol

Free Radical Biology and Medicine, 1994
We tested whether Ambroxol, a drug which stimulates the release of surfactant by pneumocytes type II, may also possess antioxidant properties. To assess the reactivity of Ambroxol with reactive oxygen species, we analysed its ability to decompose hydrogen peroxide (H2O2) and to inhibit the superoxide (O2.-)-dependent autooxidation of pyrogallol ...
Dariusz Nowak   +2 more
exaly   +3 more sources

Effect of Ambroxol of neutrophil chemotaxisin vitro

Agents and Actions, 1988
Ambroxol hydrochloride has been shown to protect the lung from damage by polymorphonuclear leucocyte (PMN). In view of this observation we have studied the effect of Ambroxol on PMN chemotaxis using a variety of chemoattractants. The PMN response was inhibited 50-80% by preincubating the cells with concentrations of 10(-4) M Ambroxol.
Stockley R A, Burnett D
exaly   +3 more sources

Ambroxol Is a Scavenger of Hypochlorous Acid and Monochloramine

Pharmacology, 2008
Experimental studies have suggested that ambroxol, a drug clinically used to enhance pulmonary surfactant production, may also exert some anti-inflammatory effects, though specific mechanisms are not yet fully understood. Thus, potential scavenging properties of ambroxol towards the most toxic neutrophil-arising prooxidants hypochlorous acid and ...
LAPENNA, Domenico   +3 more
openaire   +3 more sources

A Controlled Trial of Ambroxol in Chronic Bronchitis

Chest, 1987
Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.
G H, Guyatt   +3 more
openaire   +2 more sources

Ambroxol-Induced Focal Epileptic Seizure

Clinical Neuropharmacology, 2014
It is well known that in epileptic patients some compounds and different drugs used for the treatment of comorbidities can facilitate or provoke seizures, this evidence regarding a wide spectrum of pharmacological categories. The potential facilitating factors usually include direct toxic effects or pharmacological interactions of either active ...
LAPENTA, Leonardo   +6 more
openaire   +2 more sources

Sonolytic debromination of ambroxol process wastewater

Water Research, 2003
In this study ultrasound was examined in terms of its effectiveness in treating wastewater containing ambroxol and process water from ambroxol synthesis. The organic bromine contents of the water samples investigated were in the 20-1200 mg l(-1) range. Ultrasound is capable to debrominate the ambroxol molecule rendering it biologically degradable.
Holger, Brüggemann   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy